{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:57Z","timestamp":1791389097053,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.survophthal.2026.03.017","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:05:43Z","timestamp":1774713943000},"page":"1273-1286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5644-861X","authenticated-orcid":false,"given":"Kareem","family":"Sadek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad R.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan K.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Ani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edsel","family":"Ing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3818-9788","authenticated-orcid":false,"given":"Peng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41598-023-27753-7","article-title":"Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion","volume":"13","author":"Aljundi","year":"2023","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.survophthal.2026.03.017_bib2","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00417-020-04886-3","article-title":"Choroidal vascularity index and choriocapillary changes in retinal vein occlusions","volume":"258","author":"Aribas","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.03.017_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog Retin Eye Res"},{"issue":"10, ement","key":"10.1016\/j.survophthal.2026.03.017_bib4","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.ophtha.2016.04.056","article-title":"Anti\u2013vascular endothelial growth factor agents in the treatment of retinal disease: from bench to bedside","volume":"123","author":"Campochiaro","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.03.017_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00417-020-04983-3","article-title":"Choroidal thickening in retinal vein occlusion patients with serous retinal detachment","volume":"259","author":"Chen","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000496195","article-title":"Microvascular retinal and choroidal changes in retinal vein occlusion analyzed by two different optical coherence tomography angiography devices","volume":"242","author":"Costanzo","year":"2019","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.survophthal.2026.03.017_bib7","first-page":"141","article-title":"NB. Long-term results of ranibizumab, dexamethasone implant, and triamcinolone in macular edema due to branch retinal vein occlusion","volume":"4","author":"Yumusak","year":"2019","journal-title":"Beyoglu Eye J"},{"issue":"12","key":"10.1016\/j.survophthal.2026.03.017_bib8","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.ophtha.2013.08.031","article-title":"Subfoveal choroidal thickness in retinal vein occlusion","volume":"120","author":"Du","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.03.017_bib9","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s00417-024-06562-2","article-title":"Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion","volume":"262","author":"Dursun","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40942-019-0183-x","article-title":"Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion","volume":"5","author":"Hall","year":"2019","journal-title":"Int J Retin Vitr"},{"issue":"22","key":"10.1016\/j.survophthal.2026.03.017_bib11","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.3390\/diagnostics14222484","article-title":"Influence of Aflibercept on Choroidal Blood Flow and Thickness in Branch Retinal Vein Occlusion: A Six-Month Follow-Up Study","volume":"14","author":"Hashimoto","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.survophthal.2026.03.017_bib12","unstructured":"Higgins, Thomas J., Chandler J., et al. Cochrane Handbook for Systematic Reviews of Interventions (current version) | Cochrane [Internet]. 2024 [cited 2025 Sept 22]. Available from: \u3008https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\u3009."},{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib13","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1038\/s41598-023-30239-1","article-title":"Long-term changes in the choroidal thickness in patients with unilateral central retinal vein occlusion","volume":"13","author":"Hwang","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12886-024-03298-9","article-title":"Characteristics of macular edema associated with retinal vein occlusion showing poor anatomic response to three loading anti-vascular endothelial growth factor injections: an optical coherence tomography analysis","volume":"24","author":"Johari","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.03.017_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41433-021-01808-3","article-title":"Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment","volume":"36","author":"Kanda","year":"2022","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/IAE.0000000000001495","article-title":"Significant reduction of peripapillary choroidal thickness in patients with unilateral branch retinal vein occlusion","volume":"38","author":"Kang","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.03.017_bib17","article-title":"Changes in peripapillary and subfoveal choroidal thickness in patients with central retinal vein occlusion","volume":"16","author":"Kang","year":"2021"},{"key":"10.1016\/j.survophthal.2026.03.017_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"10.1016\/j.survophthal.2026.03.017_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3341\/jkos.2019.60.8.740","article-title":"Subfoveal Choroidal Thickness Changes after Intravitreal Bevacizumab in Macular Edema Secondary to Retinal Vein Occlusion","volume":"60","author":"Lee","year":"2019","journal-title":"J Korean Ophthalmol Soc"},{"issue":"5","key":"10.1016\/j.survophthal.2026.03.017_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.18240\/ijo.2021.05.14","article-title":"Short-term effects of intravitreal Conbercept injection combined with laser photocoagulation on macular edema secondary to ischemic retinal vein occlusion","volume":"14","author":"Liu","year":"2021","journal-title":"Int J Ophthalmol"},{"issue":"16","key":"10.1016\/j.survophthal.2026.03.017_bib21","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.3390\/jcm11164756","article-title":"Choroidal Vascularity Index in Central and Branch Retinal Vein Occlusion","volume":"11","author":"Loiudice","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2026.03.017_bib23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjophthalmol-2020-316214","article-title":"Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion","volume":"105","author":"Mitamura","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.03.017_bib24","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.2147\/OPTH.S379373","article-title":"Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions","volume":"16","author":"Moleiro","year":"2022","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"11","key":"10.1016\/j.survophthal.2026.03.017_bib25","first-page":"2210","article-title":"Macular blood flow changes in branch retinal vein occlusion examined by optical coherence tomography angiography variable interscan time analysis","volume":"42","author":"Nishigori","year":"2022","journal-title":"Retin Philos Pa"},{"issue":"11","key":"10.1016\/j.survophthal.2026.03.017_bib26","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1167\/iovs.18-23994","article-title":"Pathophysiological role of vegf on retinal edema and nonperfused areas in mouse eyes with retinal vein occlusion","volume":"59","author":"Nishinaka","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2026.03.017_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/2013.jamaophthalmol.228","article-title":"Association of inflammatory factors with macular edema in branch retinal vein occlusion","volume":"131","author":"Noma","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.03.017_bib28","doi-asserted-by":"crossref","unstructured":"Noma H., Yasuda K., Mimura T., Shimura M. Relationship between choroidal findings and growth factors, cytokines, and other inflammatory mediators after intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion. 2022;","DOI":"10.1097\/IAE.0000000000003362"},{"issue":"3","key":"10.1016\/j.survophthal.2026.03.017_bib29","first-page":"550","article-title":"Choroidal blood flow and thickness as predictors for response to anti-vascular endothelial growth factor therapy in macular edema secondary to branch retinal vein occlusion","volume":"38","author":"Okamoto","year":"2018","journal-title":"Retin Philos Pa"},{"key":"10.1016\/j.survophthal.2026.03.017_bib30","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.survophthal.2026.03.017_bib31","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s40123-023-00731-y","article-title":"Longitudinal assessment of the choroidal vascularity index in eyes with branch retinal vein occlusion-associated cystoid macular edema","volume":"12","author":"Pant","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"10.1016\/j.survophthal.2026.03.017_bib32","first-page":"999","article-title":"Park J, Lee S, Son Y. Effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion","volume":"9","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.03.017_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40942-025-00727-9","article-title":"Changes of choroidal thickness and choroidal vascularity index in patients with macular edema secondary to branch retinal vein occlusion after intravitreal ranibizumab","volume":"11","author":"Qi","year":"2025","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.survophthal.2026.03.017_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajo.2016.08.026","article-title":"Baseline choroidal thickness as a predictor for treatment outcomes in central retinal vein occlusion","volume":"171","author":"Rayess","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.03.017_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/bjophthalmol-2018-311898","article-title":"Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion","volume":"103","author":"Rayess","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.03.017_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2026.03.017_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000512357","article-title":"Relationship between recurrence of macular edema due to branch retinal vein occlusion and changes in choroidal thickness","volume":"64","author":"Sakanishi","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.03.017_bib38","first-page":"123","article-title":"Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)","volume":"242","author":"Schmidt-Erfurth","year":"2019","journal-title":"Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd"},{"issue":"10266","key":"10.1016\/j.survophthal.2026.03.017_bib39","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott","year":"2020","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"10.1016\/j.survophthal.2026.03.017_bib40","article-title":"Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion","volume":"2020","author":"Shalchi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2026.03.017_bib41","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.survophthal.2026.03.017_bib42","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.survophthal.2026.03.017_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajo.2013.04.008","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion","volume":"156","author":"Tsuiki","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.03.017_bib44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1159\/000531498","article-title":"Effects of intravitreal ranibizumab injection to treat macular edema due to central retinal vein occlusion on choroidal findings and functional-morphological parameters","author":"Yasuda","year":"2023","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.03.017_bib45","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5301\/ejo.5000734","article-title":"Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion","volume":"26","author":"Yumusak","year":"2016","journal-title":"Eur J Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:58:55Z","timestamp":1784278735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0039625726000500"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.03.017","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}